MX2023007224A - Agonistas del receptor del polipeptido tipo glucagon 1 (glp-1) de accion prolongada y metodos de uso de los mismos. - Google Patents
Agonistas del receptor del polipeptido tipo glucagon 1 (glp-1) de accion prolongada y metodos de uso de los mismos.Info
- Publication number
- MX2023007224A MX2023007224A MX2023007224A MX2023007224A MX2023007224A MX 2023007224 A MX2023007224 A MX 2023007224A MX 2023007224 A MX2023007224 A MX 2023007224A MX 2023007224 A MX2023007224 A MX 2023007224A MX 2023007224 A MX2023007224 A MX 2023007224A
- Authority
- MX
- Mexico
- Prior art keywords
- glp
- methods
- receptor agonist
- polypeptides
- agonist polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063126736P | 2020-12-17 | 2020-12-17 | |
| PCT/US2021/063920 WO2022133148A1 (en) | 2020-12-17 | 2021-12-16 | Long acting glucagon like polypeptide-1 (glp-1) receptor agonists and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023007224A true MX2023007224A (es) | 2023-09-05 |
Family
ID=80123475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023007224A MX2023007224A (es) | 2020-12-17 | 2021-12-16 | Agonistas del receptor del polipeptido tipo glucagon 1 (glp-1) de accion prolongada y metodos de uso de los mismos. |
Country Status (13)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240118914A (ko) | 2021-01-20 | 2024-08-05 | 바이킹 테라퓨틱스 인코포레이티드 | 대사 및 간 질환 치료를 위한 조성물 및 방법 |
| CA3231953A1 (en) | 2021-09-15 | 2023-03-23 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| AU2024218747A1 (en) * | 2023-02-10 | 2025-08-28 | Hangzhou Sciwind Biosciences Co., Ltd. | Polypeptide and derivative thereof, composition, and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100256056A1 (en) | 2007-09-07 | 2010-10-07 | Zheng Xin Dong | Analogues of exendin-4 and exendin-3 |
| EP3323423B1 (en) | 2009-09-28 | 2020-06-17 | Intarcia Therapeutics, Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
| JP6165168B2 (ja) * | 2011-12-22 | 2017-07-19 | ファイザー・インク | 抗糖尿病化合物 |
| UA116217C2 (uk) * | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| KR20240037175A (ko) * | 2016-05-16 | 2024-03-21 | 인타르시아 세라퓨틱스 인코포레이티드 | 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법 |
| CA3025592A1 (en) * | 2016-06-09 | 2017-12-14 | Medimmune Limited | Protease-resistant mono-lipidated peptides |
| CN111333714A (zh) * | 2020-03-05 | 2020-06-26 | 成都奥达生物科技有限公司 | 一种长效glp-1化合物 |
-
2021
- 2021-12-16 CN CN202180089098.0A patent/CN116917311A/zh active Pending
- 2021-12-16 US US17/553,381 patent/US12084485B2/en active Active
- 2021-12-16 KR KR1020237023789A patent/KR20230156689A/ko active Pending
- 2021-12-16 MX MX2023007224A patent/MX2023007224A/es unknown
- 2021-12-16 CA CA3202389A patent/CA3202389A1/en active Pending
- 2021-12-16 EP EP21851897.5A patent/EP4263587A1/en not_active Withdrawn
- 2021-12-16 IL IL303686A patent/IL303686A/en unknown
- 2021-12-16 AU AU2021400738A patent/AU2021400738A1/en active Pending
- 2021-12-16 JP JP2023537184A patent/JP2024502740A/ja active Pending
- 2021-12-16 WO PCT/US2021/063920 patent/WO2022133148A1/en not_active Ceased
- 2021-12-16 AR ARP210103539A patent/AR124395A1/es unknown
- 2021-12-17 TW TW110147341A patent/TW202237628A/zh unknown
-
2023
- 2023-06-15 ZA ZA2023/06290A patent/ZA202306290B/en unknown
-
2024
- 2024-07-22 US US18/779,857 patent/US20250034225A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024502740A (ja) | 2024-01-23 |
| EP4263587A1 (en) | 2023-10-25 |
| US12084485B2 (en) | 2024-09-10 |
| WO2022133148A1 (en) | 2022-06-23 |
| CN116917311A (zh) | 2023-10-20 |
| TW202237628A (zh) | 2022-10-01 |
| ZA202306290B (en) | 2026-03-25 |
| AR124395A1 (es) | 2023-03-22 |
| AU2021400738A1 (en) | 2023-07-13 |
| IL303686A (en) | 2023-08-01 |
| US20230063420A1 (en) | 2023-03-02 |
| KR20230156689A (ko) | 2023-11-14 |
| CA3202389A1 (en) | 2022-06-23 |
| US20250034225A1 (en) | 2025-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020201322B2 (en) | Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same | |
| JP7030894B2 (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体のすべてに活性を有する三重活性体 | |
| ES2322293T3 (es) | Agonistas de pyy y usos de los mismos. | |
| ES2537287T3 (es) | Análogos de glucagón acilados | |
| Bernichtein et al. | Development of pure prolactin receptor antagonists | |
| JP6391589B2 (ja) | 官能基化されたエキセンディン−４誘導体 | |
| CN105745222B (zh) | 酰化胰高血糖素类似物 | |
| JP6731958B2 (ja) | 選択的ｐｙｙ化合物及びその使用 | |
| AU2011247452B2 (en) | Peptide conjugates of GLP-1 receptor agonists and gastrin and their use | |
| KR101813595B1 (ko) | 장기적 생체 내 효능을 갖는 성장 호르몬 | |
| MX2022013024A (es) | Analogos del peptido tirosina tirosina (pyy) de accion prolongada y metodos de uso de los mismos. | |
| US11478551B2 (en) | Long-acting adrenomedullin derivative | |
| Joshi et al. | Recombinant thyrotropin containing a beta-subunit chimera with the human chorionic gonadotropin-beta carboxy-terminus is biologically active, with a prolonged plasma half-life: role of carbohydrate in bioactivity and metabolic clearance | |
| JP2016138127A (ja) | 心臓病の処置 | |
| US20150376257A1 (en) | Glucagon analogues | |
| TW201202265A (en) | Glucagon analogues | |
| RU2017146657A (ru) | Пролекарства, содержащие коньюгат гиалуроновой кислоты, ликера и и двойного агониста glp-1глюкагона | |
| AR124395A1 (es) | Agonistas del receptor del polipéptido tipo glucagón 1 (glp-1) de acción prolongada y métodos de uso de los mismos | |
| JP2013524807A (ja) | 高親和性レプチン及びレプチンアンタゴニスト | |
| JP2008515443A (ja) | 新規のアミリンファミリーポリペプチド−６（ａｆｐ−６）アナログならびにそれらの製法および使用方法 | |
| Huang et al. | Characterization of glucagon-like peptide 1 receptor (GLP1R) gene in chickens: functional analysis, tissue distribution, and identification of its transcript variants | |
| JP2023144098A (ja) | ポリペプチドを含む医薬組成物 | |
| MX2022013023A (es) | Peptidos selectivos del receptor de glucagon de accion prolongada y metodos de uso. | |
| EP1325930A1 (en) | Mammal prolactin variants | |
| Niv-Spector et al. | Large-scale preparation and characterization of non-pegylated and pegylated superactive ovine leptin antagonist |